Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
- PMID: 26295295
- PMCID: PMC4594327
- DOI: 10.17305/bjbms.2015.432
Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome
Abstract
Obesity, insulin resistance (IR), inflammation, and hyperandrogenism may lead to polycystic ovary syndrome (PCOS) and hypertension. Nesfatin-1 (N1) may be related to IR, obesity, and hypertension. Furthermore, a vitamin D (VD) deficiency is associated with hypertension and PCOS. We aimed to investigate N1 and VD levels in PCOS that have an effect on systolic and diastolic blood pressure (BP) and heart rate (HR).This study included 54 patients with PCOS and 48 age-body mass index (BMI)-matched healthy controls. PCOS was diagnosed according to clinical practice guidelines. Ferriman-Gallwey scores (FGS) were calculated, while N1, VD, and other hormonal and biochemical parameters were measured for all subjects. Systolic and diastolic BP was measured as well. HR was calculated using an electrocardiogram.The levels of N1 (p < 0.001), high-sensitivity C-reactive protein (hs-CRP) (p = 0.036), homeostasis model assessment as an index of insulin resistance (HOMA-IR) (p < 0.001), systolic (p < 0.001) and diastolic (p < 0.001) BP and HR (p < 0.001) in the PCOS group were significantly higher than in the control group. However, the VD levels of the PCOS group were lower than the control group (p = 0.004). N1 had a strong positive correlation with BMI, HOMA-IR, hs-CRP, luteinizing hormone, systolic and diastolic BP, and HR. VD levels were negatively correlated with HOMA-IR and luteinizing hormone.Elevated N1 and decreased VD levels may be related to the presence of high-normal BP or hypertension in PCOS subjects. N1 level may be associated with an increased BP due to its relation to inflammation and IR.
Similar articles
-
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19. Gynecol Endocrinol. 2014. PMID: 25137507
-
Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2851-6. Eur Rev Med Pharmacol Sci. 2014. PMID: 25339479
-
Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome.Gynecol Endocrinol. 2015 Jul;31(7):543-7. doi: 10.3109/09513590.2015.1024219. Epub 2015 Jun 10. Gynecol Endocrinol. 2015. PMID: 26062107
-
Nucleobindin-2 derived nesfatin-1 in polycystic ovary syndrome: a PRISMA and GRADE-compliant systematic review and meta-analysis with diagnostic test accuracy.Minerva Endocrinol (Torino). 2024 Mar;49(1):111-121. doi: 10.23736/S2724-6507.23.04003-4. Epub 2023 Nov 9. Minerva Endocrinol (Torino). 2024. PMID: 37943280
-
Vitamin D and Polycystic Ovary Syndrome: a Narrative Review.Reprod Sci. 2021 Aug;28(8):2110-2117. doi: 10.1007/s43032-020-00369-2. Epub 2020 Oct 28. Reprod Sci. 2021. PMID: 33113105 Review.
Cited by
-
Can Nesfatin-1 Predict Hypertension in Obese Children?J Clin Res Pediatr Endocrinol. 2020 Mar 19;12(1):29-36. doi: 10.4274/jcrpe.galenos.2019.2019.0072. Epub 2019 Jul 24. J Clin Res Pediatr Endocrinol. 2020. PMID: 31339256 Free PMC article.
-
Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens.Physiology (Bethesda). 2017 Sep;32(5):357-366. doi: 10.1152/physiol.00030.2016. Physiology (Bethesda). 2017. PMID: 28814496 Free PMC article. Review.
-
Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome.Eurasian J Med. 2019 Oct;51(3):280-284. doi: 10.5152/eurasianjmed.2019.18420. Epub 2019 Aug 19. Eurasian J Med. 2019. PMID: 31692710 Free PMC article. Review.
-
Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.Int J Reprod Biomed. 2023 Nov 24;21(10):777-788. doi: 10.18502/ijrm.v21i10.14533. eCollection 2023 Oct. Int J Reprod Biomed. 2023. PMID: 38077942 Free PMC article. Review.
-
Associations between plasma nesfatin-1 levels and the presence and severity of coronary artery disease.Heart Vessels. 2019 Jun;34(6):965-970. doi: 10.1007/s00380-018-01328-3. Epub 2019 Jan 1. Heart Vessels. 2019. PMID: 30599062
References
-
- Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–231. http://dx.doi.org/10.1038/nrendo.2010.217 . - PubMed
-
- Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038–2049. http://dx.doi.org/10.1210/jc.2009-2724 . - PubMed
-
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. http://dx.doi.org/10.1210/er.2011-1034 . http://dx.doi.org/10.1210/er.2011-1034 . - PMC - PubMed
-
- Oh IS, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443(7112):709–712. http://dx.doi.org/10.1038/nature05162 . - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous